Stephen Machatha - Mar 4, 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Chief Development Officer
Signature
/s/ Stephen Machatha
Stock symbol
ALDX
Transactions as of
Mar 4, 2025
Transactions value $
$0
Form type
4
Date filed
3/6/2025, 04:13 PM
Previous filing
Aug 14, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (right to buy) Award $0 +202K $0.00 202K Mar 4, 2025 Common Stock 202K $6.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.